Author

Guillaume Lefèvre

Université de LilleORCID 0000-0002-9427-7267Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Amélie Bigorgne· 1 shared Angélique Lebouvier· 1 shared Anne GoffardiD· 1 shared Anne-Florence Collange· 1 shared Audrey Tarricone· 1 shared C. MéniiD· 1 shared Caroline Kabore· 1 shared Céline RivièreiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amélie Bigorgne

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 3, 2025

AXL mediates mast cell survival and resistance to tyrosine kinase inhibitors in mastocytosis

Kitsada Kangboonruang, Philippe Drabent, Fatlinda Maksut…·Leïla Maouche-Chrétien

This study identifies AXL as a driver of mast cell survival and TKI resistance in mastocytosis and shows that dual KIT/AXL inhibition restores TKI sensitivity.

DOI 10.1101/2025.11.03.686205

humanproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintApr 9, 2024

Major Metabolites From Hypericum perforatum L., Hyperforin And Hypericin, Are Both Active Against Human Coronaviruses

Imelda Raczkiewicz, Céline Rivière, Peggy Bouquet…·Karin Séron

This study shows that hyperforin from Hypericum perforatum inhibits multiple coronaviruses, including SARS-CoV-2, with antiviral activity confirmed in human cells and potential for combination therapy with remdesivir.

1 citation

humanmetabolomics

𝕏 PostBluesky